Oscar Health Inc. (OSCR) Misses Q4 EPS by 35c; offers guidance

Oscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($1.24), $0.35 worse than the analyst estimate of ($0.89). Revenue for the quarter came in at $2.81 billion versus the consensus estimate of $3.11 billion.

GUIDANCE:

Oscar Health Inc. sees FY2026 revenue of $18.7-19 billion, versus the consensus of $12.756 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance